Roivant Sciences Ltd.
ROIV$33.62+1.45% 1D
$15.9052-week range$42.50
Updated . Prices are snapshots and may be delayed.
Roivant Sciences Ltd. price chart
−1.53% over 7D
$35.41
$33.37
Oct 18
Oct 20
AI Outlook for Roivant Sciences Ltd.
Neutral posture- Long-term trend+10.8% vs 200-day average
- Medium-term trend-7.2% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Roivant Sciences Ltd. performance
1D
+1.4%
7D
−0.5%
30D
−13.8%
90D
−1.4%
1Y
+97.2%
About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a biotechnology company based in the United Kingdom, listed on NASDAQ since 2020 (ticker ROIV).
Roivant Sciences Ltd. market data
What is the price of Roivant Sciences Ltd. today?
Roivant Sciences Ltd. (ROIV) is at $33.62, +1.45% on the day.
What is the 52-week range of Roivant Sciences Ltd.?
Over the past year Roivant Sciences Ltd. has traded between $15.90 and $42.50. It is currently 67% of the way up that range.
Similar stocks
IBRX
Immunitybio Inc
$9.91+2.3%
VSTM
Verastem Inc
$7.71−3.6%
GRML
Greenland Mines Ltd
$6.49−13.6%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$2.07−43.8%
BDRX
Biodexa Pharmaceuticals PLC
$0.4849−2.6%
RXRX
Recursion Pharmaceuticals, Inc.
$3.74+0.5%
MRNA
Moderna, Inc.
$226.30+4.1%
AKBA
Akebia Therapeutics, Inc.
$0.702−6.4%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.